Literature DB >> 10490613

Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways.

H Holtmann1, R Winzen, P Holland, S Eickemeier, E Hoffmann, D Wallach, N L Malinin, J A Cooper, K Resch, M Kracht.   

Abstract

A hallmark of inflammation is the burst-like formation of certain proteins, initiated by cellular stress and proinflammatory cytokines like interleukin 1 (IL-1) and tumor necrosis factor, stimuli which simultaneously activate different mitogen-activated protein (MAP) kinases and NF-kappaB. Cooperation of these signaling pathways to induce formation of IL-8, a prototype chemokine which causes leukocyte migration and activation, was investigated by expressing active and inactive forms of protein kinases. Constitutively active MAP kinase kinase 7 (MKK7), an activator of the stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) pathway, induced IL-8 synthesis and transcription from a minimal IL-8 promoter. Furthermore, MKK7 synergized in both effects with NF-kappaB-inducing kinase (NIK). Activation of the IL-8 promoter by either of the kinases required functional NF-kappaB and AP-1 sites. While NIK and MKK7 did not affect degradation of IL-8 mRNA, an active form of MKK6, which selectively activates p38 MAP kinase, induced marked stabilization of the transcript and further increased IL-8 protein formation induced by NIK plus MKK7. Consistently, the MAP kinase kinase kinase MEKK1, which can activate NF-kappaB, SAPK/JNK, and p38 MAP kinases, most potently induced IL-8 formation. These results provide evidence that maximal IL-8 gene expression requires the coordinate action of at least three different signal transduction pathways which cooperate to induce mRNA synthesis and suppress mRNA degradation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490613      PMCID: PMC84667          DOI: 10.1128/MCB.19.10.6742

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  68 in total

1.  Transcriptional and post-transcriptional regulation of interleukin-8.

Authors:  L H Villarete; D G Remick
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

2.  Synergistic activation of interleukin-8 gene transcription by all-trans-retinoic acid and tumor necrosis factor-alpha involves the transcription factor NF-kappaB.

Authors:  H Harant; R de Martin; P J Andrew; E Foglar; C Dittrich; I J Lindley
Journal:  J Biol Chem       Date:  1996-10-25       Impact factor: 5.157

3.  Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating kappaB enhancer activation.

Authors:  C F Meyer; X Wang; C Chang; D Templeton; T H Tan
Journal:  J Biol Chem       Date:  1996-04-12       Impact factor: 5.157

4.  MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway.

Authors:  J Raingeaud; A J Whitmarsh; T Barrett; B Dérijard; R J Davis
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

Review 5.  AU-rich elements: characterization and importance in mRNA degradation.

Authors:  C Y Chen; A B Shyu
Journal:  Trends Biochem Sci       Date:  1995-11       Impact factor: 13.807

6.  Regulation of interleukin-8 gene expression by interleukin-1beta, osteotropic hormones, and protein kinase inhibitors in normal human bone marrow stromal cells.

Authors:  L R Chaudhary; L V Avioli
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

7.  A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA.

Authors:  S H Ridley; J L Dean; S J Sarsfield; M Brook; A R Clark; J Saklatvala
Journal:  FEBS Lett       Date:  1998-11-13       Impact factor: 4.124

8.  Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2.

Authors:  A Lin; A Minden; H Martinetto; F X Claret; C Lange-Carter; F Mercurio; G L Johnson; M Karin
Journal:  Science       Date:  1995-04-14       Impact factor: 47.728

9.  c-jun N-terminal kinase is involved in AUUUA-mediated interleukin-3 mRNA turnover in mast cells.

Authors:  X F Ming; M Kaiser; C Moroni
Journal:  EMBO J       Date:  1998-10-15       Impact factor: 11.598

10.  Osmotic regulation of cytokine synthesis in vitro.

Authors:  L Shapiro; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

View more
  84 in total

1.  p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis.

Authors:  M Warny; A C Keates; S Keates; I Castagliuolo; J K Zacks; S Aboudola; A Qamar; C Pothoulakis; J T LaMont; C P Kelly
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 2.  FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis.

Authors:  A Krueger; S Baumann; P H Krammer; S Kirchhoff
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

3.  RASSF7 negatively regulates pro-apoptotic JNK signaling by inhibiting the activity of phosphorylated-MKK7.

Authors:  S Takahashi; A Ebihara; H Kajiho; K Kontani; H Nishina; T Katada
Journal:  Cell Death Differ       Date:  2010-11-19       Impact factor: 15.828

4.  EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway.

Authors:  R Bonavia; M M Inda; S Vandenberg; S-Y Cheng; M Nagane; P Hadwiger; P Tan; D W Y Sah; W K Cavenee; F B Furnari
Journal:  Oncogene       Date:  2011-12-05       Impact factor: 9.867

Review 5.  Cell type- and stimulus-specific mechanisms for post-transcriptional control of neutrophil chemokine gene expression.

Authors:  Thomas Hamilton; Xiaoxia Li; Michael Novotny; Paul G Pavicic; Shyamasree Datta; Chenyang Zhao; Justin Hartupee; Dongxu Sun
Journal:  J Leukoc Biol       Date:  2011-12-13       Impact factor: 4.962

6.  IRAK-4 mutation (Q293X): rapid detection and characterization of defective post-transcriptional TLR/IL-1R responses in human myeloid and non-myeloid cells.

Authors:  Donald J Davidson; Andrew J Currie; Dawn M E Bowdish; Kelly L Brown; Carrie M Rosenberger; Rebecca C Ma; Johan Bylund; Paul A Campsall; Anne Puel; Capucine Picard; Jean-Laurent Casanova; Stuart E Turvey; Robert E W Hancock; Rebecca S Devon; David P Speert
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

7.  An antiapoptotic protein, c-FLIPL, directly binds to MKK7 and inhibits the JNK pathway.

Authors:  Akihito Nakajima; Sachiko Komazawa-Sakon; Mutsuhiro Takekawa; Tomonari Sasazuki; Wen-Chen Yeh; Hideo Yagita; Ko Okumura; Hiroyasu Nakano
Journal:  EMBO J       Date:  2006-11-16       Impact factor: 11.598

8.  The type III pseudomonal exotoxin U activates the c-Jun NH2-terminal kinase pathway and increases human epithelial interleukin-8 production.

Authors:  Alayne Cuzick; Fiona R Stirling; Susan L Lindsay; Thomas J Evans
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

9.  The Yersinia enterocolitica effector YopP inhibits host cell signalling by inactivating the protein kinase TAK1 in the IL-1 signalling pathway.

Authors:  Axel Thiefes; Alexander Wolf; Anneke Doerrie; Guntram A Grassl; Kunihiro Matsumoto; Ingo Autenrieth; Erwin Bohn; Hiroaki Sakurai; Rainer Niedenthal; Klaus Resch; Michael Kracht
Journal:  EMBO Rep       Date:  2006-07-14       Impact factor: 8.807

Review 10.  The potential of p38 MAPK inhibitors to modulate periodontal infections.

Authors:  Keith L Kirkwood; Carlos Rossa
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.